Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion ...

Patients with diabetic kidney disease (DKD) and anemia have no worse, and possibly better, cardiovascular outcomes from finerenone treatment.

Updated, longer-term results from the COMMANDS trial show a promising trend toward improved overall survival with ...

The study, conducted across multiple centers in Japan and published in Advances in Therapy, was led by Dr. Osamu Wada-Hiraike ...

A ctDNA-guided approach can help identify when patients with HR-positive advanced breast cancer are developing an ESR1 ...

Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the ...

Relacorilant/nab-paclitaxel significantly improved PFS and OS vs nab-paclitaxel alone in platinum-resistant ovarian cancer.

PARP inhibitors demonstrate synergy with radiation, so investigators tested the efficacy and safety of olaparib plus radium-223 in patients with mCRPC and bone metastases in a phase 2 trial.

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

A new study published in the Korean Journal of Anesthesiology showed that preoperative anemia may be associated with a higher ...